Condition
Ehlers Danlos Syndrome
Total Trials
6
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Enrolling By Invitation1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04806620Recruiting
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
NCT07083713Not ApplicableEnrolling By Invitation
Group Coaching Study for Life Goals
NCT01367977CompletedPrimary
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
NCT02985710Not ApplicableCompleted
Assessment of Small Fiber Neuropathy in Rare Diseases Using Sudoscan
NCT02712060CompletedPrimary
Obstructive Sleep Apnoea in Children and Adolescents With Ehlers-Danlos Syndrome
NCT00001641Completed
Study of Heritable Connective Tissue Disorders
Showing all 6 trials